LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Accueil・Liste d'Actions・Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc

Fermé

Secteur Soins de santé

27.78 1.87

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

27.83

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+143.08 upside

Dividendes
By Dow Jones
Prochains Résultats	30 oct. 2024

Sentiment de l'Actualité

By Acuity

20%

80%

47 / 366 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bearish Evidence

59.71 / 72.47 Support & Résistance

Apellis Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 oct. 2024, 22:33 UTC

Actualités

New Zealand's Inflation Back Within Band; RBNZ Set to Continue Slashing Rates

15 oct. 2024, 21:35 UTC

Principaux Mouvements du Marché

Novocure Shares Rise After FDA Approves Optune Lua Cancer Treatment

15 oct. 2024, 19:26 UTC

Résultats

Trending: Johnson & Johnson Posts Higher-Than-Expected Sales

15 oct. 2024, 19:24 UTC

Principaux Mouvements du Marché

Oklo Shares Climb 22% After DOE Approves Fuel Fabrication Facility Concept

15 oct. 2024, 18:40 UTC

Principaux Mouvements du Marché

Montrose Environmental Shares Up 17% After Securing $249 Million U.S. Army Contract

15 oct. 2024, 18:24 UTC

Actualités

Louis Vuitton Owner LVMH Misses Third-Quarter Revenue Expectations Amid Luxury Slowdown -- 2nd Update

15 oct. 2024, 17:32 UTC

Résultats

Adidas Raises Full-Year Guidance on Brand Momentum, Third-Quarter Results -- Update

15 oct. 2024, 23:48 UTC

Market Talk

Gold Steady Ahead of Major U.S. Economic Data, Fed Official's Speech -- Market Talk

15 oct. 2024, 22:54 UTC

Acquisitions, Fusions, Rachats

Berkshire's Move to Sell Apple Doesn't Look Good. It May Have Left $25 Billion on the Table. -- Barrons.com

15 oct. 2024, 22:45 UTC

Acquisitions, Fusions, Rachats

Berkshire's Move to Sell Apple Doesn't Look Good. It May Have Left $25 Billion on the Table. -- Barrons.com

15 oct. 2024, 21:33 UTC

Résultats

Schwab's Latest Earnings Are a Turning Point for the Beleaguered Stock. 4 Big Takeaways. -- Barrons.com

15 oct. 2024, 21:08 UTC

Actualités

Boeing, Needing Cash, Moves to Sell New Shares -- 2nd Update

15 oct. 2024, 20:56 UTC

Actualités

Résultats

Morgan Stanley Earnings Expected to Ride Investment Banking Wave -- Barrons.com

15 oct. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

15 oct. 2024, 20:50 UTC

Market Talk

Résultats

Health Care Roundup: Market Talk

15 oct. 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15 oct. 2024, 20:38 UTC

Résultats

Nvidia Stock Falls After ASML Earnings Leak Early. Why the Drop Is an Overreaction. -- Barrons.com

15 oct. 2024, 20:20 UTC

Résultats

Interactive Brokers Slides On Earnings Miss. Charles Schwab Ends Streak Of Losses. -- IBD

15 oct. 2024, 20:18 UTC

Actualités

Slump in Chip Stocks Weighs on Indexes -- WSJ

15 oct. 2024, 19:41 UTC

Résultats

Bank of America Bond Losses Narrowed to $85.7 Billion. They Still Lead the Industry. -- Barrons.com

15 oct. 2024, 19:30 UTC

Market Talk

Oil Futures Drop As Fear of Supply Disruption Eases -- Market Talk

15 oct. 2024, 19:19 UTC

Market Talk

U.S. Natural Gas Futures Strive to Hold $2.50 -- Market Talk

15 oct. 2024, 19:14 UTC

Market Talk

Gold Rises as Equity Markets Slip -- Market Talk

15 oct. 2024, 18:53 UTC

Market Talk

Card Activity Shows Four Retailers Topping 3Q Forecasts -- Market Talk

15 oct. 2024, 18:43 UTC

Market Talk

Résultats

LVMH Sounds Caution On Recovery In U.S. Luxury Goods Market -- Market Talk

15 oct. 2024, 18:04 UTC

Actualités

Résultats

Three Big Takeaways From Bank Earnings -- WSJ

15 oct. 2024, 18:04 UTC

Actualités

Investors Weigh Earnings From Goldman, Citi and BofA -- WSJ

15 oct. 2024, 17:56 UTC

Résultats

Nvidia Stock Falls After ASML Earnings Leak Early. Why the Drop Is an Overreaction. -- Barrons.com

15 oct. 2024, 17:51 UTC

Résultats

Merrill Lynch Client Assets Spike 18% to $3.5 Trillion -- Barrons.com

15 oct. 2024, 17:51 UTC

Résultats

Nvidia Stock Falls After ASML Earnings Leak Early. Why the Drop Is an Overreaction. -- Barrons.com

Comparaison

Variation de prix

Apellis Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

143.08% hausse

Prévisions sur 12 Mois

Moyen 67.94 USD 143.08%

Haut 95 USD

Bas 39 USD

Basé sur 17 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

17 ratings

Achat

Maintien

Vente

Basé sur 17 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

59.71 / 72.47Support & Résistance

Recent bearish events outweigh bullish events.

All events are bullish.

There is one bullish event.

Sentiment

By Acuity

47 / 366Classement par Soins de santé

Autres valeurs du secteur

LLY

Eli Lilly and Co.

916.07

↓-0.02%

UNH

UnitedHealth Group Inc

566.13

↓-0.87%

NVO

Novo Nordisk A-S

118.17

↑ +0.23%

JNJ

Johnson and Johnson

164.55

↑ +0.16%

ABBV

AbbVie Inc

188.57

↓-1%

Apellis Pharmaceuticals Inc

Résumé

Variation du prix de l'action

Recommandations

Dividendes

Sentiment de l'Actualité

Score Technique

Apellis Pharmaceuticals Inc Graphique

Actualités Associées

Comparaison

Apellis Pharmaceuticals Inc prévision

Objectif de Prix

Note du Consensus

Score Technique

Sentiment

Autres valeurs du secteur

Informations cruciales sur les comptes Facebook